scholarly journals The therapeutic response in Gorham’s syndrome to the beta-blocking agent propranolol is correlated to VEGF-A, but not to VEGF-C or FLT1 expression

2015 ◽  
Vol 8 (1) ◽  
Author(s):  
Jessica Baud ◽  
Abderrahim Lomri ◽  
Denis Graber ◽  
Andreas Bikfalvi
Keyword(s):  
Therapeutic Response ◽  
Blocking Agent ◽  
Beta Blocking ◽  
Flt1 Expression ◽  
Gorham’S Syndrome

A radioautographic study on the incorporation of 14C-bupranolol (beta-blocking agent) into the rabbit eye

1980 ◽  
Vol 68 (3) ◽  
pp. 237-244 ◽  
Author(s):  
S. Tsukahara ◽  
K. Yoshida ◽  
T. Nagata
Keyword(s):  
Blocking Agent ◽  
Rabbit Eye ◽  
Beta Blocking

Prevention of Adrenaline-Induced Metabolic Systemic and Myocardial Alterations by the Beta-Blocking Agent Metipranolol in the Dog

Cardiology ◽  
1981 ◽  
Vol 67 (4) ◽  
pp. 206-218 ◽  
Author(s):  
K. Herbaczyńska-Cedro ◽  
B. Woźniewicz ◽  
B. Broniszeẃska-Ardelt ◽  
L. Ceremużyński
Keyword(s):  
Blocking Agent ◽  
Beta Blocking

scholarly journals Clinical electrophysiological effects of atenolol--a new cardioselective beta-blocking agent.

Heart ◽  
1978 ◽  
Vol 40 (1) ◽  
pp. 14-21 ◽  
Author(s):  
C Robinson ◽  
J Birkhead ◽  
B Crook ◽  
K Jennings ◽  
D Jewitt
Keyword(s):  
Blocking Agent ◽  
Beta Blocking ◽  
Electrophysiological Effects

Generalized Convulsions in a Patient Receiving Ultrashort-Acting Beta-Blocker Infusion

1988 ◽  
Vol 22 (6) ◽  
pp. 484-485 ◽  
Author(s):  
Gopal Das ◽  
Janine C. Ferris
Keyword(s):  
Heart Disease ◽  
Beta Blocker ◽  
Blocking Agent ◽  
Literature Survey ◽  
Receptor Blocking ◽  
Blocking Agents ◽  
Beta Receptor ◽  
Generalized Seizures ◽  
Beta Blocking ◽  
Therapeutic Doses

Beta-receptor blocking agents are commonly used to treat patients with heart disease, and generalized seizures due to therapy with these agents are rare. All reported cases of seizures due to beta blocking agents have occurred only in those subjects who ingested large doses of the drugs. We observed generalized convulsions in a patient who was receiving therapeutic doses of an ultrashort-acting beta-blocking agent (esmolol hydrochloride) intravenously. A literature survey and possible mechanisms by which these agents induce seizures are presented.

scholarly journals Bisoprolol, a once-a-day beta-blocking agent for patients with mild to moderate hypertension

1994 ◽  
Vol 17 (5) ◽  
pp. 263-268 ◽  
Author(s):  
Michael E. Davidov ◽  
Sant P. Singh ◽  
Nicolas D. Vlachakis ◽  
Jerome B. Blumenthal ◽  
Joseph S. Simon ◽  
...  
Keyword(s):  
Moderate Hypertension ◽  
Blocking Agent ◽  
Beta Blocking
Sign in / Sign up

Export Citation Format

Share Document